zilurgisertib,elotuzumab
incyte,abbvie,bms
['mpnsm', '#mpn', 'zilurgisertib', 'elotuzumab']
was good to present at #eha23 the first results from our ist on elotuzumab - clearly an active drug in mf - and an encore from #asco23 of the zilurgisertib (acvr1/alk2i) data showing anemia responses and hepcidin downregulation! #mpnsm 
Associate Professor, Leukemia at MD Anderson; myeloproliferative neoplasm expert, NCCN panelist. Tweets reflect my own views; not necessarily my institution's.